<VariationArchive RecordType="classified" VariationID="31054" VariationName="NM_015972.4(POLR1D):c.88_89dup (p.Gln31fs)" VariationType="Duplication" Accession="VCV000031054" Version="1" NumberOfSubmissions="1" NumberOfSubmitters="1" DateLastUpdated="2022-04-25" DateCreated="2013-04-04" MostRecentSubmission="2013-04-04">
  <RecordStatus>current</RecordStatus>
  <Species>Homo sapiens</Species>
  <ClassifiedRecord>
    <SimpleAllele AlleleID="40011" VariationID="31054">
      <GeneList>
        <Gene Symbol="POLR1D" FullName="RNA polymerase I and III subunit D" GeneID="51082" HGNC_ID="HGNC:20422" Source="submitted" RelationshipType="within single gene">
          <Location>
            <CytogeneticLocation>13q12.2</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="13" Accession="NC_000013.11" start="27620743" stop="27667411" display_start="27620743" display_stop="27667411" Strand="+" />
            <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="13" Accession="NC_000013.10" start="28194879" stop="28241558" display_start="28194879" display_stop="28241558" Strand="+" />
          </Location>
          <OMIM>613715</OMIM>
          <Haploinsufficiency last_evaluated="2021-06-23" ClinGen="https://www.ncbi.nlm.nih.gov/projects/dbvar/ISCA/isca_gene.cgi?sym=POLR1D">Sufficient evidence for dosage pathogenicity</Haploinsufficiency>
          <Triplosensitivity last_evaluated="2021-06-23" ClinGen="https://www.ncbi.nlm.nih.gov/projects/dbvar/ISCA/isca_gene.cgi?sym=POLR1D">No evidence available</Triplosensitivity>
        </Gene>
      </GeneList>
      <Name>NM_015972.4(POLR1D):c.88_89dup (p.Gln31fs)</Name>
      <CanonicalSPDI>NC_000013.11:27622935:GT:GTGT</CanonicalSPDI>
      <VariantType>Duplication</VariantType>
      <Location>
        <CytogeneticLocation>13q12.2</CytogeneticLocation>
        <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" forDisplay="true" AssemblyStatus="current" Chr="13" Accession="NC_000013.11" start="27622935" stop="27622936" display_start="27622935" display_stop="27622936" variantLength="2" positionVCF="27622935" referenceAlleleVCF="G" alternateAlleleVCF="GGT" />
        <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="13" Accession="NC_000013.10" start="28197072" stop="28197073" display_start="28197072" display_stop="28197073" variantLength="2" positionVCF="28197072" referenceAlleleVCF="G" alternateAlleleVCF="GGT" />
      </Location>
      <ProteinChange>Q31fs</ProteinChange>
      <HGVSlist>
        <HGVS Assembly="GRCh37" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000013.10" sequenceAccession="NC_000013" sequenceVersion="10" change="g.28197073_28197074dup" Assembly="GRCh37">
            <Expression>NC_000013.10:g.28197073_28197074dup</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Assembly="GRCh38" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000013.11" sequenceAccession="NC_000013" sequenceVersion="11" change="g.27622936_27622937dup" Assembly="GRCh38">
            <Expression>NC_000013.11:g.27622936_27622937dup</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="NG_028908.1" sequenceAccession="NG_028908" sequenceVersion="1" change="g.7194_7195dup">
            <Expression>NG_028908.1:g.7194_7195dup</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_015972.4" sequenceAccession="NM_015972" sequenceVersion="4" change="c.88_89dup" MANESelect="true">
            <Expression>NM_015972.4:c.88_89dup</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_057056.1" sequenceAccession="NP_057056" sequenceVersion="1" change="p.Gln31fs">
            <Expression>NP_057056.1:p.Gln31fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001206559.2" sequenceAccession="NM_001206559" sequenceVersion="2" change="c.-59+1796_-59+1797dup">
            <Expression>NM_001206559.2:c.-59+1796_-59+1797dup</Expression>
          </NucleotideExpression>
          <MolecularConsequence ID="SO:0001627" Type="intron variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_152705.3" sequenceAccession="NM_152705" sequenceVersion="3" change="c.26+927_26+928dup">
            <Expression>NM_152705.3:c.26+927_26+928dup</Expression>
          </NucleotideExpression>
          <MolecularConsequence ID="SO:0001627" Type="intron variant" DB="SO" />
        </HGVS>
      </HGVSlist>
      <XRefList>
        <XRef Type="Allelic variant" ID="613715.0006" DB="OMIM" />
        <XRef Type="rs" ID="1593275363" DB="dbSNP" />
      </XRefList>
      <Comment DataSource="ClinGen" Type="public">ClinGen staff contributed the HGVS expression for this variant.</Comment>
    </SimpleAllele>
    <RCVList>
      <RCVAccession Title="NM_015972.4(POLR1D):c.88_89dup (p.Gln31fs) AND Treacher Collins syndrome 2" Accession="RCV000024048" Version="2">
        <ClassifiedConditionList TraitSetID="7238">
          <ClassifiedCondition DB="MedGen" ID="C3150983">Treacher Collins syndrome 2</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>no assertion criteria provided</ReviewStatus>
            <Description DateLastEvaluated="2011-01-01" SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
    </RCVList>
    <Classifications>
      <GermlineClassification DateLastEvaluated="2011-01-01" NumberOfSubmissions="1" NumberOfSubmitters="1" DateCreated="2013-04-04" MostRecentSubmission="2013-04-04">
        <ReviewStatus>no assertion criteria provided</ReviewStatus>
        <Description>Pathogenic</Description>
        <Citation Type="general">
          <ID Source="PubMed">21131976</ID>
        </Citation>
        <ConditionList>
          <TraitSet ID="7238" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="15804" Type="Disease">
              <Name>
                <ElementValue Type="Alternate">TREACHER COLLINS SYNDROME 2, AUTOSOMAL RECESSIVE</ElementValue>
                <XRef Type="Allelic variant" ID="613715.0007" DB="OMIM" />
              </Name>
              <Name>
                <ElementValue Type="Preferred">Treacher Collins syndrome 2</ElementValue>
                <XRef ID="Treacher+collins+syndrome+2/9423" DB="Genetic Alliance" />
                <XRef ID="MONDO:0013385" DB="MONDO" />
              </Name>
              <Symbol>
                <ElementValue Type="Preferred">TCS2</ElementValue>
                <XRef Type="MIM" ID="613717" DB="OMIM" />
              </Symbol>
              <AttributeSet>
                <Attribute Type="public definition">Treacher Collins syndrome (TCS) is characterized by bilateral and symmetric downslanting palpebral fissures, malar hypoplasia, micrognathia, and external ear abnormalities. Hypoplasia of the zygomatic bones and mandible can cause significant feeding and respiratory difficulties. About 40%-50% of individuals have conductive hearing loss attributed most commonly to malformation of the ossicles and hypoplasia of the middle ear cavities. Inner ear structures tend to be normal. Other, less common abnormalities include cleft palate and unilateral or bilateral choanal stenosis or atresia. Typically intellect is normal.</Attribute>
                <XRef ID="NBK1532" DB="GeneReviews" />
              </AttributeSet>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">20301704</ID>
                <ID Source="BookShelf">NBK1532</ID>
              </Citation>
              <XRef ID="861" DB="Orphanet" />
              <XRef ID="C3150983" DB="MedGen" />
              <XRef ID="MONDO:0013385" DB="MONDO" />
              <XRef Type="MIM" ID="613717" DB="OMIM" />
            </Trait>
          </TraitSet>
        </ConditionList>
      </GermlineClassification>
    </Classifications>
    <ClinicalAssertionList>
      <ClinicalAssertion ID="50595" SubmissionDate="2011-03-01" DateLastUpdated="2013-04-04" DateCreated="2013-04-04">
        <ClinVarSubmissionID localKey="613715.0006_TREACHER COLLINS SYNDROME 2" title="POLR1D, 2-BP INS, 88TG_TREACHER COLLINS SYNDROME 2" />
        <ClinVarAccession Accession="SCV000045339" DateUpdated="2013-04-04" DateCreated="2013-04-04" Type="SCV" Version="1" SubmitterName="OMIM" OrgID="3" OrganizationCategory="resource" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2011-01-01">
          <ReviewStatus>no assertion criteria provided</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species>human</Species>
              <AffectedStatus>not provided</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>literature only</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">In a mother and daughter with Treacher Collins syndrome-2 (613717), Dauwerse et al. (2011) identified heterozygosity for a 2-bp insertion (88insTG) in exon 3 of the POLR1D gene, resulting in a frameshift and premature termination codon. The mutation was not found in 280 controls.</Attribute>
              <Citation>
                <ID Source="PubMed">21131976</ID>
              </Citation>
              <XRef DB="OMIM" ID="613717" Type="MIM" />
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="POLR1D" />
          </GeneList>
          <Name>POLR1D, 2-BP INS, 88TG</Name>
          <VariantType>Variation</VariantType>
          <OtherNameList>
            <Name Type="NonHGVS">2-BP INS, 88TG</Name>
          </OtherNameList>
          <XRefList>
            <XRef DB="OMIM" ID="613715.0006" Type="Allelic variant" />
          </XRefList>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <Name>
              <ElementValue Type="Preferred">TREACHER COLLINS SYNDROME 2</ElementValue>
            </Name>
          </Trait>
        </TraitSet>
      </ClinicalAssertion>
    </ClinicalAssertionList>
    <TraitMappingList>
      <TraitMapping ClinicalAssertionID="50595" TraitType="Disease" MappingType="Name" MappingValue="TREACHER COLLINS SYNDROME 2" MappingRef="Preferred">
        <MedGen CUI="C3150983" Name="Treacher Collins syndrome 2" />
      </TraitMapping>
    </TraitMappingList>
  </ClassifiedRecord>
</VariationArchive>

